Cancer Therapy Market to Cross US $78 Billion by 2012

Delhi, India (PressExposure) April 01, 2009 -- “Global Cancer Treatment Forecast to 2012", a new research report from RNCOS, states that the global cancer drugs market is expected to surpass US $78 Billion by 2012.

As per the report, cancer is the most rapidly growing segment of treatment in the pharmaceutical market. Thus, this segment has become a centre of attention for the drug companies and investors across the world. Also, this segment has gained higher attention as compared to other therapy segments.

The foremost reason for the immense attention gained by the cancer therapy segment is the escalating prevalence of this disease as well as the huge number of needs that are yet to be met in the field of cancer treatment. Resultantly, drug firms worldwide are eager to grab a significant share in this highly potential market. Though launching a drug successfully may be risky, but if a company is able to do this, then it observes boundless commercial gains.

Presently, a number of drugs are available for the cancer treatment, but while providing some relief, these drugs also cause serious side effects to the patients as they tend to damage the healthy cells alongwith the cancerous cells. Hence, pharma companies around the world are making efforts to formulate drugs having maximum efficacy and minimal side-effects.

Giving a due consideration to these facts, the report says that the growth in cancer market is anticipated to be driven by the launch of new vaccines and various target therapies like antiangiogenics and monoclonal antibodies (anti-neoplastic Mabs). With the development of these drugs, there will be significant reduction in the severity of side-effects in the coming times.

“Global Cancer Treatment Forecast to 2012” is an exhaustive study on the worldwide cancer treatment market, giving crucial statistics and analysis on the prevalence of cancer, market structure, market size, key drug segments, important trends in technology development, major opportunities, and market shares of key players and drugs. The report throws a light on both past and present market trends along with the factors that may influence the market in the coming times. The report may prove crucial for the firms or investors seeking investments in the concerned sector.

For FREE SAMPLE of this report visit: [http://www.rncos.com/Report/IM130.htm]

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS E-Services Pvt. Ltd.

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Press Release Source: http://PressExposure.com/PR/RNCOS_E~Services_Pvt._Ltd..html

Press Release Submitted On: March 30, 2009 at 12:34 am
This article has been viewed 17883 time(s).